上海昊海生物科技股份有限公司 关于开立募集资金现金管理产品专用结算账户的公告

Core Viewpoint - The company has approved the use of temporarily idle raised funds for cash management, allowing up to RMB 300 million for investment in safe and liquid financial products, ensuring that it does not affect the normal investment plans of the raised funds [1] Group 1: Cash Management Approval - The company convened its sixth board meeting on November 7, 2025, and approved the proposal to use temporarily idle raised funds for cash management [1] - The maximum amount for cash management is set at RMB 300 million, which can be used for investments in secure and liquid products such as time deposits and certificates of deposit [1] - The investment period is valid for 12 months from the date of board approval, and the funds can be used in a rolling manner within the specified limits [1] Group 2: Special Settlement Account - The company has opened a special settlement account for cash management products to facilitate the management of raised funds [2] - The account will be used exclusively for the settlement of temporarily idle raised funds and will not be used for non-raised funds or other purposes [2] - The account will be closed promptly when cash management products mature and there are no further purchase plans [2] Group 3: Risk Control Measures - The finance department will analyze and monitor the investment direction and project progress of bank cash management products, taking timely protective measures if adverse factors are identified [2] - The audit committee and independent directors have the authority to supervise and inspect the use of funds, and may hire professional institutions for auditing if necessary [2] - The company will strictly adhere to relevant regulations and timely fulfill information disclosure obligations [2] Group 4: Impact on the Company - The establishment of the special settlement account and the planned use of idle raised funds for cash management will not affect the implementation of investment projects or the safety of raised funds [3] - The cash management of temporarily idle funds is expected to generate investment returns, which will enhance the overall performance of the company and provide better returns for shareholders [3]

HAOHAI BIOTEC-上海昊海生物科技股份有限公司 关于开立募集资金现金管理产品专用结算账户的公告 - Reportify